European Centre for Disease Prevention and Control: EU Fails to Meet WHO Hepatitis Elimination Targets by 2030

• The European Centre for Disease Prevention and Control has identified remaining gaps in hepatitis prevention measures, particularly in vaccination and harm reduction services.
• The WHO target of eliminating hepatitis B and C by 2030 remains out of reach due to these persistent gaps.
• Lawyers advising clients on public health initiatives in the EU should monitor developments related to the elimination of hepatitis B and C.

The WHO target of eliminating hepatitis B and C by 2030 remains out of reach due to these persistent gaps.

The European Centre for Disease Prevention and Control has highlighted the need to address remaining gaps in hepatitis prevention measures, particularly in vaccination and harm reduction services. Despite progress made in reducing vertical transmission of hepatitis B from mother to child, many countries still struggle to ensure a safe supply of blood, tissues, and cells. This is a common challenge faced by public health initiatives across Europe, where life-saving interventions are often inaccessible to those who need them most. The WHO target of eliminating hepatitis B and C by 2030 remains out of reach due to these persistent gaps.

Lawyers advising clients on public health initiatives in the EU should monitor developments related to the elimination of hepatitis B and C. Compliance with WHO targets may have implications for funding and resource allocation, making it essential for legal professionals to stay informed about progress towards these goals. The EU's commitment to strengthening prevention measures is reflected in its efforts to reduce vertical transmission of hepatitis B and ensure a safe blood supply. However, the challenge of closing remaining gaps in prevention measures will require continued collaboration between public health experts, policymakers, and legal professionals.

The elimination of hepatitis B and C by 2030 is not only a public health goal but also a matter of human rights. Ensuring that life-saving interventions are accessible to everyone who needs them is crucial for reducing health inequities and promoting social justice. As the EU works towards meeting its WHO target, it is essential to address the persistent gaps in prevention measures and ensure that all individuals have access to necessary services and treatments. This will require a sustained commitment to public health initiatives and a willingness to adapt and improve prevention strategies as needed.

Lawyers advising clients on public health initiatives in the EU should monitor developments related to the elimination of hepatitis B and C, as compliance with WHO targets may have implications for funding and resource allocation.

Source: Original reporting via World Hepatitis Day 2026